Following Neu-1 inhibition, OP exerted its anti-cancer effects through increased E-cadherin expression and decreased VE-cadherin and N-cadherin in human pancreatic cells (PANC1) as EMT and E-cadherin loss [133]. The gene discussed is NEU1; the disease is cancer.